Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (69K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Mymryk, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mymryk, J. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research Pages 292-294  


Database of mutations within the adenovirus 5 E1A oncogene
Introduction
Database Content
Database Availability
Acknowledgements
References


Database of mutations within the adenovirus 5 E1A oncogene

Database of mutations within the adenovirus 5 E1A oncogene

Joe S. Mymryk

Departments of Oncology and Pharmacology & Toxicology, The University of Western Ontario, London Regional Cancer Centre, 790 Commissioners Road East, London, Ontario N6A 4L6, Canada

Received August 15, 1997; Revised and Accepted September 24, 1997

ABSTRACT

The Ad5 E1A database is a listing of mutations affecting the early region 1A (E1A) proteins of human adenovirus type 5. The database contains the name of the mutation, the nucleic acid sequence changes, the resulting alterations in amino acid sequence and reference. Additional notes and references are provided on the effect of each mutation on E1A function. The database is contained within the Adenovirus 5 E1A page on the World Wide Web at:http://www.geocities.com/CapeCanaveral/Hangar/2541/

INTRODUCTION

The proteins encoded by early region 1A (E1A) of human adenovirus type 5 (Ad5) are useful tools with which to investigate the regulation of cell growth and development. In the infected cell, the E1A proteins act as potent regulators of viral and cellular gene transcription to establish an optimal environment for viral replication. The multi-functional E1A proteins also induce quiescent cells to enter and traverse the cell cycle, block differentiation, immortalize primary rodent cells and transform them in co-operation with a second oncogene (1-5). Besides these oncogenic properties, E1A can also function as an anti-oncogene to suppress transformation, metastasis and tumorigenicity and induce apoptosis (6,7). These many functions have made E1A a powerful tool to dissect cellular regulatory processes.

Five distinct mRNA products are produced from the primary E1A transcript by alternative splicing (8-10) (Fig. 1A). These encode two major proteins of 289 and 243 residues (R), and several less abundant E1A proteins (Fig. 1B). With the exception of the 9S E1A mRNA, the reading frame of each mRNA remains conserved after splicing. Thus, the 243, 217 and 171R E1A proteins represent edited versions of the larger 289R E1A protein. Comparison of the E1A sequence of a number of adenovirus serotypes has identified three regions of sequence conservation (11,12), designated conserved regions (CR) 1, 2 and 3 (Fig. 1B). These regions play important roles in mediating many E1A activities (1-5).


Figure 1 Schematic representation of the structure of the E1A transcription and translation products. (A) The primary E1A transcript is alternatively spliced to generate five mRNA products ranging in size from 13S to 9S. The locations of the cap, translation start, translation stop, polyadenylation and splicing sites are indicated at the top. Coding regions are represented as filled rectangles. (B) The E1A gene encodes five related proteins ranging in size from 289 to 55 residues (R). Three regions of amino acid sequence that are conserved between the E1A proteins of various adenovirus serotypes are indicated as stippled, hatched or solid rectangles, respectively. The boundaries of these three conserved regions (CR) are labelled with respect to their locations in the 289R E1A product. The sequence of the second exon encoded portion of the 55R product differs from that of the other E1A proteins due to a change in reading frame, and this is indicated by the shaded rectangle.

The E1A proteins are not sequence specific DNA binding proteins, but instead act by binding to a variety of cellular proteins, including members of the p300 and pRB family of regulatory proteins (1-5). By targeting these and other cellular proteins, E1A alters or inhibits their normal functions in the cell, thereby reprogramming growth and development.

Studies of E1A function have been greatly facilitated by the use of E1A mutants. Analyses of the phenotypes of a battery of mutants have established strong correlations between various E1A activities and identified important links between E1A function and its association with cellular factors (1-5). Mutational analyses have further demonstrated that E1A is a modular protein, containing multiple domains that can function independently, and sometimes redundantly, to provoke changes in cell regulation (1,5). Intriguingly, domains homologous to those first identified in E1A by mutational analysis have been found in a number of other viral (13-15) and cellular (16-21) proteins, providing immediate insight into their mechanism of action.

DATABASE CONTENT

The database of mutations within the Ad5 E1A oncogene is intended as a resource for researchers using E1A to investigate mechanisms of cell regulation. The database was compiled from an extensive search of the literature and contains an ordered listing of >400 E1A mutants constructed in laboratories throughout the world. The database contains the name of the mutation, the nucleic acid sequence changes of the mutation (where available), the resulting alterations in amino acid sequence (where available) and reference (Table 1). Additional notes and references are provided on the effect of the mutation on E1A function. Although not yet comprehensive, the database continues to grow and additional mutants are added as information becomes available. This database should be a valuable resource for those interested in using E1A to study cellular processes.


Table 1. Sample from the database of Ad5 E1A mutations

Note: deletions listed are inclusive and amino acid numbering is with respect to the 289R E1A protein.


DATABASE AVAILABILITY

The database of mutations affecting the Ad5 E1A proteins is contained within the Adenovirus 5 E1A page on the World Wide Web at http://www.geocities.com/CapeCanaveral/Hangar/2541/ . In order to make it as useful as possible, I encourage others in the field to provide additions and corrections, which can be submitted using the electronic form provided within the database, or alternatively can be emailed to myself at: jmymryk@julian.uwo.ca.

ACKNOWLEDGEMENTS

I would like to thank Dr S.T. Bayley for introducing me to the E1A proteins of Ad5. I also thank Geocities for providing web space for the Ad5 E1A page and Database.

REFERENCES

1. Bayley,S.T. and Mymryk,J.S. (1994) Int. J. Oncology, 5, 425-444.

2. Peeper,D.S. and Zantema,A. (1993) Mol. Biol. Rep., 17, 197-207. MEDLINE Abstract

3. Dyson,N. and Harlow,E. (1992) Cancer Surv., 12, 161-195. MEDLINE Abstract

4. Shenk,T. and Flint,J. (1991) Adv. Cancer Res., 57, 47-85. MEDLINE Abstract

5. Moran,E. (1994) Semin. Virol., 5, 327-340.

6. Chinnadurai,G. (1992) Oncogene, 7, 1255-1258. MEDLINE Abstract

7. Mymryk,J.S. (1996) Oncogene, 13, 1581-1589. MEDLINE Abstract

8. Perricaudet,M., Akusjarvi,G., Virtanen,A. and Patterson,U. (1979) Nature, 281, 694-696. MEDLINE Abstract

9. Stephens,C. and Harlow,E. (1987) EMBO J., 6, 2027-2035. MEDLINE Abstract

10. Ulfendahl,P.J., Linder,S., Kreivi,J., Nordqvist,K., Sevensson,C., Hultberg,H. and Akusjarvi,G. (1987) EMBO J., 6, 2037-2044. MEDLINE Abstract

11. Kimelman,D., Miller,J.S., Porter,D. and Roberts,B.E. (1985) J. Virol., 53, 399-409. MEDLINE Abstract

12. van Ormondt,H., Maat,J. and Dijkema,R. (1980) Gene, 12, 63-76. MEDLINE Abstract

13. Moran,E. (1988) Nature, 334, 168-170. MEDLINE Abstract

14. Xie,Q., Suarez Lopez,P. and Gutierrez,C. (1995) EMBO J., 14, 4073-4082. MEDLINE Abstract

15. Phelps,W.C., Yee,C.L., Munger,K. and Howley,P.M. (1988) Cell, 53, 539-547. MEDLINE Abstract

16. Dowdy,S.F., Hinds,P.W., Louie,K., Reed,S.I., Arnold,A. and Weinberg,R.A. (1993) Cell, 73, 499-511. MEDLINE Abstract

17. Defeo-Jones,D., Huang,P.S., Jones,R.E., Haskell,K.M., Vuocolo,G.A., Hanobik,M.G., Huber,H.E. and Oliff,A. (1991) Nature, 352, 251-254. MEDLINE Abstract

18. Tevosian,S.G., Shih,H.H., Mendelson,K.G., Sheppard,K.A., Paulson,K.E. and Yee,A.S. (1997) Genes Dev., 11, 383-396. MEDLINE Abstract

19. Chen,C.F., Chen,Y., Dai,K., Chen,P.L., Riley,D.J. and Lee,W.H. (1996) Mol. Cell. Biol., 16, 4691-4699. MEDLINE Abstract

20. Wang,C.Y., Petryniak,B., Thompson,C.B., Kaelin,W.G. and Leiden,J.M. (1993) Science, 260, 1330-1335. MEDLINE Abstract

21. Ozaki,T. and Sakiyama,S. (1996) DNA Cell Biol., 15, 975-979. MEDLINE Abstract

22. Stein,R.W., Corrigan,M., Yaciuk,P., Whelan,J. and Moran,E. (1990) J. Virol., 64, 4421-4427. MEDLINE Abstract

23. Wang,H., Draetta,G. and Moran,E. (1991) Mol. Cell. Biol., 11, 4253-4265. MEDLINE Abstract

24. Zerler,B., Roberts,R.J., Mathews,M.B. and Moran,E. (1987) Mol. Cell. Biol., 7, 821-829. MEDLINE Abstract

25. Taylor,D.A., Kraus,V.B., Schwarz,J.J., Olson,E.N. and Kraus,W.E. (1993) Mol. Cell. Biol., 13, 4714-4727. MEDLINE Abstract

26. Kalman,D., Whittaker,K., Bishop,J.M. and O'Lague,P.H. (1993) Mol. Biol. Cell, 4, 353-361. MEDLINE Abstract

27. Kitabayashi,I., Eckner,R., Arany,Z., Chiu,R., Gachelin,G., Livingston,D.M. and Yokoyama,K.K. (1995) EMBO J., 14, 3496-3509. MEDLINE Abstract

28. Somasundaram,K., Jayaraman,G., Williams,T., Moran,E., Frisch,S. and Thimmapaya,B. (1996) Proc. Natl. Acad. Sci. USA, 93, 3088-3093. MEDLINE Abstract

29. Lillie,J.W., Green,M. and Green,M.R. (1986) Cell, 46, 1043-1051. MEDLINE Abstract

30. Bautista,D.S., Hitt,M., McGrory,J. and Graham,F.L. (1991) Virology, 182, 578-596. MEDLINE Abstract

31. Whyte,P., Williamson,N.M. and Harlow,E. (1989) Cell, 56, 67-75. MEDLINE Abstract

32. Eckner,R., Ewen,M.E., Newsome,D., Gerdes,M., DeCaprio,J.A., Lawrence,J.B. and Livingston,D.M. (1994) Genes Dev., 8, 869-884. MEDLINE Abstract

33. Caruso,M., Martelli,F., Giordano,A. and Felsani,A. (1993) Oncogene, 8, 267-278. MEDLINE Abstract

34. Duerksen-Hughes,P.J., Hermiston,T.W., Wold,W.S.M. and Gooding,L.R. (1991) J. Virol., 65, 1236-1244. MEDLINE Abstract

35. Boulukos,K.E. and Ziff,E.B. (1993) Oncogene, 8, 237-248. MEDLINE Abstract

36. Gutch,M.J. and Reich,N.C. (1991) Proc. Natl. Acad. Sci. USA, 88, 7913-7917. MEDLINE Abstract

37. Jelsma,T.N., Howe,J.A., Evelegh,C.M., Cunniff,N.F., Skiadopoulos,M.H., Floroff,M.R., Denman,J.E. and Bayley,S.T. (1988) Virology, 163, 494-502. MEDLINE Abstract

38. Caporossi,D. and Bacchetti,S. (1990) J. Gen. Virol., 71, 801-808. MEDLINE Abstract

39. Egan,C., Jelsma,T.N., Howe,J.A., Bayley,S.T., Ferguson,B. and Branton,P.E. (1988) Mol. Cell. Biol., 8, 3955-3959. MEDLINE Abstract

40. Gedrich,R.W., Bayley,S.T. and Engel,D.A. (1992) J. Virol., 66, 5849-5859. MEDLINE Abstract

41. Mymryk,J.S., Lee,R.W.H. and Bayley,S.T. (1992) Mol. Biol. Cell, 3, 1107-1115. MEDLINE Abstract

42. Slack,R.S., Craig,J., Costa,S. and McBurney,M.W. (1995) Oncogene, 10, 19-25. MEDLINE Abstract

43. Routes,J.M., Li,H., Bayley,S.T., Ryan,S. and Klemm,D.J. (1996) J. Immunol., 156, 1055-1061. MEDLINE Abstract

44. Miller,M.E., Engel,D.A. and Smith,M.M. (1995) Oncogene, 11, 1623-1630. MEDLINE Abstract

45. Boyd,J.M., Subramanian,T., Schaeper,U., La Regina,M., Bayley,S. and Chinnadurai,G. (1993) EMBO J., 12, 469-478. MEDLINE Abstract

46. Arsenault,H. and Weber,J.M. (1993) FEMS Microbiol. Lett., 114, 37-40. MEDLINE Abstract


Tel: +1 519 685 8617; Fax: +1 519 685 8616; Email: jmymryk@julian.uwo.ca


This page is run by Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, as part of the OUP Journals Comments and feedback: www-admin{at}oup.co.uk
Last modification: 17 Dec 1997
Copyright© Oxford University Press, 1998.

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
X. Zhang, A. S. Turnell, C. Gorbea, J. S. Mymryk, P. H. Gallimore, and R. J. A. Grand
The Targeting of the Proteasomal Regulatory Subunit S2 by Adenovirus E1A Causes Inhibition of Proteasomal Activity and Increased p53 Expression
J. Biol. Chem., June 11, 2004; 279(24): 25122 - 25133.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Print PDF (69K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Mymryk, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mymryk, J. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?